Jaisser F[au] - Search Results

Year	Number of Results
1987	1
1988	1
1989	3
1990	1
1991	1
1992	2
1993	5
1994	2
1995	1
1996	4
1997	1
1998	4
1999	4
2000	1
2001	1
2002	3
2003	2
2004	3
2005	3
2007	3
2008	5
2009	7
2010	7
2011	8
2012	9
2013	8
2014	13
2015	15
2016	12
2017	13
2018	17
2019	16
2020	12
2021	17
2022	18
2023	1

1

Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects.

Barrera-Chimal J, Lima-Posada I, Bakris GL, Jaisser F. Barrera-Chimal J, et al. Among authors: jaisser f. Nat Rev Nephrol. 2022 Jan;18(1):56-70. doi: 10.1038/s41581-021-00490-8. Epub 2021 Oct 21. Nat Rev Nephrol. 2022. PMID: 34675379 Review.

2

Myocardial fibrosis: biomedical research from bench to bedside.

Gyöngyösi M, Winkler J, Ramos I, Do QT, Firat H, McDonald K, González A, Thum T, Díez J, Jaisser F, Pizard A, Zannad F. Gyöngyösi M, et al. Among authors: jaisser f. Eur J Heart Fail. 2017 Feb;19(2):177-191. doi: 10.1002/ejhf.696. Eur J Heart Fail. 2017. PMID: 28157267 Free PMC article. Review.

3

Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis.

Barrera-Chimal J, Girerd S, Jaisser F. Barrera-Chimal J, et al. Among authors: jaisser f. Kidney Int. 2019 Aug;96(2):302-319. doi: 10.1016/j.kint.2019.02.030. Epub 2019 Mar 13. Kidney Int. 2019. PMID: 31133455 Review.

4

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F. Daruich A, et al. Among authors: jaisser f. Prog Retin Eye Res. 2015 Sep;48:82-118. doi: 10.1016/j.preteyeres.2015.05.003. Epub 2015 May 27. Prog Retin Eye Res. 2015. PMID: 26026923 Free article. Review.

5

Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.

Barrera-Chimal J, Jaisser F. Barrera-Chimal J, et al. Among authors: jaisser f. Diabetes Obes Metab. 2020 Apr;22 Suppl 1:16-31. doi: 10.1111/dom.13969. Diabetes Obes Metab. 2020. PMID: 32267077 Review.

6

The mineralocorticoid receptor in chronic kidney disease.

Barrera-Chimal J, Jaisser F, Anders HJ. Barrera-Chimal J, et al. Among authors: jaisser f. Br J Pharmacol. 2022 Jul;179(13):3152-3164. doi: 10.1111/bph.15734. Epub 2021 Dec 28. Br J Pharmacol. 2022. PMID: 34786690 Review.

7

Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases.

Barrera-Chimal J, Bonnard B, Jaisser F. Barrera-Chimal J, et al. Among authors: jaisser f. Annu Rev Physiol. 2022 Feb 10;84:585-610. doi: 10.1146/annurev-physiol-060821-013950. Annu Rev Physiol. 2022. PMID: 35143332 Review.

8

More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases.

Buonafine M, Martinez-Martinez E, Jaisser F. Buonafine M, et al. Among authors: jaisser f. Clin Sci (Lond). 2018 May 8;132(9):909-923. doi: 10.1042/CS20171592. Print 2018 May 16. Clin Sci (Lond). 2018. PMID: 29739822 Review.

9

CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.

Martínez-Martínez E, Brugnolaro C, Ibarrola J, Ravassa S, Buonafine M, López B, Fernández-Celis A, Querejeta R, Santamaria E, Fernández-Irigoyen J, Rábago G, Moreno MU, Jaisser F, Díez J, González A, López-Andrés N. Martínez-Martínez E, et al. Among authors: jaisser f. Hypertension. 2019 Mar;73(3):602-611. doi: 10.1161/HYPERTENSIONAHA.118.11874. Hypertension. 2019. PMID: 30612490

10

Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.

Andersson KB, Winer LH, Mørk HK, Molkentin JD, Jaisser F. Andersson KB, et al. Among authors: jaisser f. Transgenic Res. 2010 Aug;19(4):715-25. doi: 10.1007/s11248-009-9342-4. Epub 2009 Nov 6. Transgenic Res. 2010. PMID: 19894134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results